ArticleMolecular and clinical oncology2019
Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era.
Özlem Yersal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it